Nephros Inc (NEPH)
2.20
-0.13
(-5.58%)
USD |
NASDAQ |
May 03, 16:00
2.25
+0.05
(+2.27%)
After-Hours: 20:00
Nephros Cash from Financing (Quarterly): -0.003M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.003M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.002M |
| March 31, 2023 | -0.074M |
| December 31, 2022 | -0.111M |
| September 30, 2022 | -0.069M |
| June 30, 2022 | -0.067M |
| March 31, 2022 | 0.281M |
| December 31, 2021 | -0.037M |
| September 30, 2021 | 0.046M |
| June 30, 2021 | 0.231M |
| March 31, 2021 | -0.003M |
| December 31, 2020 | 4.615M |
| September 30, 2020 | -0.065M |
| June 30, 2020 | 0.028M |
| March 31, 2020 | 6.638M |
| December 31, 2019 | -0.055M |
| September 30, 2019 | 0.171M |
| June 30, 2019 | 2.038M |
| March 31, 2019 | -0.137M |
| December 31, 2018 | 0.778M |
| September 30, 2018 | 2.96M |
| June 30, 2018 | 3.016M |
| March 31, 2018 | 0.293M |
| December 31, 2017 | 0.248M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.563M |
| June 30, 2017 | -0.008M |
| March 31, 2017 | 1.187M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 1.187M |
| March 31, 2016 | 0.001M |
| December 31, 2015 | 0.689M |
| September 30, 2015 | 1.896M |
| June 30, 2015 | 1.205M |
| March 31, 2015 | 0.001M |
| December 31, 2014 | 1.069M |
| September 30, 2014 | 1.619M |
| June 30, 2014 | -0.002M |
| March 31, 2014 | 0.517M |
| December 31, 2013 | 1.305M |
| September 30, 2013 | 0.009M |
| June 30, 2013 | 1.68M |
| March 31, 2013 | 1.126M |
| December 31, 2012 | 0.052M |
| September 30, 2012 | 0.095M |
| June 30, 2012 | 0.29M |
| March 31, 2012 | 0.066M |
| December 31, 2011 | 0.173M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.111M
Minimum
Dec 2022
6.638M
Maximum
Mar 2020
0.7138M
Average
-0.002M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.237M |
| Cash from Investing (Quarterly) | -0.075M |
| Free Cash Flow | 0.827M |
| Free Cash Flow Per Share (Quarterly) | -0.0226 |
| Free Cash Flow to Equity (Quarterly) | -0.237M |
| Free Cash Flow Yield | 3.62% |